Similar articles

• Molecular, cellular and endocrine signalling in the perinatal cardiovascular system: interplay and developmental programming.

  Magness RR, Poston L. Magness RR, et al. J Physiol. 2005 May 15;565(Pt 1):1. doi: 10.1113/jphysiol.2005.086744. Epub 2005 Mar 24. J Physiol. 2005. PMID: 15790658 Free PMC article. No abstract available.
• Molecular targets of tea polyphenols in the cardiovascular system.

  Stangl V, Dreger H, Stangl K, Lorenz M. Stangl V, et al. Cardiovasc Res. 2007 Jan 15;73(2):348-58. doi: 10.1016/j.cardiores.2006.08.022. Epub 2006 Sep 1. Cardiovasc Res. 2007. PMID: 17020753 Review.
• Regulation of Rho proteins by phosphorylation in the cardiovascular system.

  Loirand G, Guilluy C, Pacaud P. Loirand G, et al. Trends Cardiovasc Med. 2006 Aug;16(6):199-204. doi: 10.1016/j.tcm.2006.03.010. Trends Cardiovasc Med. 2006. PMID: 16839863 Review.
• Physiologic stress-mediated signaling in the endothelium.

  Reinhart-King CA, Fujiwara K, Berk BC. Reinhart-King CA, et al. Methods Enzymol. 2008;443:25-44. doi: 10.1016/S0076-6879(08)02002-8. Methods Enzymol. 2008. PMID: 18772009
• Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction?

  Schubert R. Schubert R. Cardiovasc Res. 2006 Apr 1;70(1):9-11. doi: 10.1016/j.cardiores.2006.02.012. Epub 2006 Feb 23. Cardiovasc Res. 2006. PMID: 16542647 No abstract available.